First marketing approval granted for Vitrase in Mexico; U.S. phase III trials now under way Nov. 24, 1998
Ozagrel hydrochloride effectively prevents development of preeclampsia in pregnant women Nov. 19, 1998
ML Laboratories granted second license from U.K. authorities for its dry powder inhaler Nov. 17, 1998
RSS